The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications
Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76, 2982–3021 (2020).
Google Scholar
Benjamin, E. J. et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 137, e67–e492 (2018).
Google Scholar
Kazi, D. S. et al. Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: a presidential advisory from the American Heart Association. Circulation 150, e89–e101 (2024).
Google Scholar
Mann, D. L. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ. Res. 108, 1133–1145 (2011).
Google Scholar
Hansson, G. K. The heart of immunology: immune mechanisms in cardiovascular medicine. Cardiovasc. Res. 117, e166–e168 (2021).
Google Scholar
Roy, P., Orecchioni, M. & Ley, K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat. Rev. Immunol. 22, 251–265 (2022).
Google Scholar
Bartoli-Leonard, F., Zimmer, J. & Aikawa, E. Innate and adaptive immunity: the understudied driving force of heart valve disease. Cardiovasc. Res. 117, e166–e168 (2021).
Chen, R. et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal. Transduct. Target Ther. 9, 130 (2024).
Google Scholar
Varricchi, G., Marone, G. & Kovanen, P. T. Cardiac mast cells: underappreciated immune cells in cardiovascular homeostasis and disease. Trends Immunol. 41, 734–746 (2020).
Google Scholar
Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576–1588 (2019).
Google Scholar
Chen, L. et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. cell 167, 1398–1414 (2016).
Google Scholar
Martini, E. et al. Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation. Circulation 140, 2089–2107 (2019).
Google Scholar
Abendstein, L., et al. Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains. Nat. Commun. 14, 4027 (2023).
Google Scholar
Rurik, J. G., Aghajanian, H. & Epstein, J. A. Immune cells and immunotherapy for cardiac injury and repair. Circ. Res. 128, 1766–1779 (2021).
Google Scholar
Rurik, J. G. et al. CAR T cells produced in vivo to treat cardiac injury. Science 375, 91–96 (2022).
Google Scholar
Lüscher, T. F. The sooner, the better: anti-inflammation in acute myocardial infarction. Eur. Heart J. 41, 4100–4102 (2020).
Google Scholar
Stamler, J. & Katz, L. N. Production of experimental cholesterol-induced atherosclerosis in chicks with minimal hypercholesterolemia and organ lipidosis. Circulation 2, 705–713 (1950).
Google Scholar
Aqel, N. M., Ball, R. Y., Waldmann, H. & Mitchinson, M. J. Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J. Pathol. 146, 197–204 (1985).
Google Scholar
Jonasson, L. et al. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Investig. 76, 125–131 (1985).
Google Scholar
Jonasson, L. et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131–138 (1986).
Google Scholar
Emeson, E. E. & Robertson, A. L. Jr. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am. J. Pathol. 130, 369–376 (1988).
Google Scholar
Hansson, G. K., Holm, J. & Jonasson, L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135, 169–175 (1989).
Google Scholar
Wedler, F. C., Hoffmann, F. M., Kenney, R. & Carfi, J. Maintainance of specificity, information, and thermostability in thermophilic Bacillus sp. glutamine synthetase. Experientia Suppl. 26, 187–197 (1976).
Google Scholar
Nallamothu, B. K. et al. Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis. Circulation 113, 222–229 (2006).
Google Scholar
Yellon, D. M. & Hausenloy, D. J. Myocardial reperfusion injury. N. Engl. J. Med. 357, 1121–1135 (2007).
Google Scholar
Fantone, J. C. & Ward, P. A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 107, 395–418 (1982).
Google Scholar
Babior, B. M., Kipnes, R. S. & Curnutte, J. T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Investig. 52, 741–744 (1973).
Google Scholar
Meerson, F. Z. et al. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res. Cardiol. 77, 465–485 (1982).
Google Scholar
Dick, S. A. & Epelman, S. Chronic heart failure and inflammation: what do we really know?. Circ. Res. 119, 159–176 (2016).
Google Scholar
Levine, B. et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236–241 (1990).
Google Scholar
Ferrari, R. et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92, 1479–1486 (1995).
Google Scholar
Borrelli, E. et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit. Care Med. 24, 392–397 (1996).
Google Scholar
Liuzzo, G. et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med. 331, 417–424 (1994).
Google Scholar
Ridker, P. M., Hennekens, C. H., Buring, J. E. & Rifai, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342, 836–843 (2000).
Google Scholar
Ridker, P. M., Rifai, N., Stampfer, M. J. & Hennekens, C. H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101, 1767–1772 (2000).
Google Scholar
Ridker, P. M. et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101, 2149–2153 (2000).
Google Scholar
Roman, M. J. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2399–2406 (2003).
Google Scholar
Moos, M. P. et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb. Vasc. Biol. 25, 2386–2391 (2005).
Google Scholar
Hu, D. et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors. Immunity 42, 1100–1115 (2015).
Google Scholar
Depuydt, M. A. C. et al. Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics. Circ. Res. 127, 1437–1455 (2020).
Google Scholar
Sun, X. et al. Meta-analysis of single-cell RNA-Seq data reveals the mechanism of formation and heterogeneity of tertiary lymphoid organ in vascular disease. Arterioscler Thromb. Vasc. Biol. 43, 1867–1886 (2023).
Google Scholar
Kuppe, C. et al. Spatial multi-omic map of human myocardial infarction. Nature 608, 766–777 (2022).
Google Scholar
Drobni, Z. D. et al. Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque. Circulation 142, 2299–2311 (2020).
Google Scholar
Gao, T. A. & Chen, Y. Y. T cells to fix a broken heart. Science 375, 23–24 (2022).
Google Scholar
Aghajanian, H. et al. Targeting cardiac fibrosis with engineered T cells. Nature 573, 430–433 (2019).
Google Scholar
Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119–1131 (2017).
Google Scholar
Tardif, J. C. et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N. Engl. J. Med. 381, 2497–2505 (2019).
Google Scholar
Sun, K., Li, Y. Y. & Jin, J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Signal. Transduct. Target Ther. 6, 79 (2021).
Google Scholar
Simoes, F. C. & Riley, P. R. Immune cells in cardiac repair and regeneration. Development 149, dev199906 (2022).
Google Scholar
Litvinukova, M. et al. Cells of the adult human heart. Nature 588, 466–472 (2020).
Google Scholar
Yu, X. et al. Innate lymphoid cells promote recovery of ventricular function after myocardial infarction. J. Am. Coll. Cardiol. 78, 1127–1142 (2021).
Google Scholar
Adamo, L., et al. Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury. JCI Insight 3, e120137 (2018).
Google Scholar
Epelman, S. et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91–104 (2014).
Google Scholar
Perdiguero, E. G. et al. The origin of tissue-resident macrophages: when an erythro-myeloid progenitor is an erythro-myeloid progenitor. Immunity 43, 1023–1024 (2015).
Google Scholar
Molawi, K. et al. Progressive replacement of embryo-derived cardiac macrophages with age. J. Exp. Med. 211, 2151–2158 (2014).
Google Scholar
Lee, C. Z. W. & Ginhoux, F. Biology of resident tissue macrophages. Development 149, 8 (2022).
Google Scholar
Davies, L. C., Jenkins, S. J., Allen, J. E. & Taylor, P. R. Tissue-resident macrophages. Nat. Immunol. 14, 986–995 (2013).
Google Scholar
Daems, W. T. & Brederoo, P. The fine structure and peroxidase activity of resident and exudate peritoneal macrophages in the guinea pig. In The Reticuloendothelial System and Immune Phenomena (eds. Di Luzio, N. R. & Flemming, K. B. P) Advances in Experimental Medicine and Biology 15, 19–31 (Springer, Boston, MA, 1971). https://doi.org/10.1007/978-1-4684-3204-6_3.
Sabin, F., Doan, C. A. & Cunningham, R. S. Discrimination of two types of phagocytic cells in the connective tissues by the supravital technique. Embryol16, 125–162 (1925).
Randolph, G. J., Ochando, J. & Partida-Sanchez, S. Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol. 26, 293–316 (2008).
Google Scholar
van Furth, R. & Cohn, Z. A. The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415–435 (1968).
Google Scholar
van Furth, R. et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. World Health Organ 46, 845–852 (1972).
Google Scholar
Parwaresch, M. R. & Wacker, H. H. Origin and kinetics of resident tissue macrophages. Parabiosis studies with radiolabelled leucocytes. Cell Tissue Kinet. 17, 25–39 (1984).
Google Scholar
Lafuse, W. P., Wozniak, D. J. & Rajaram, M. V. S. Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair. Cells 10, 51 (2020).
Google Scholar
Hulsmans, M. et al. Macrophages facilitate electrical conduction in the heart. Cell 169, 510–522 e520 (2017).
Google Scholar
Sugita, J., et al. Cardiac macrophages prevent sudden death during heart stress. Nat. Commun. 12, 1910 (2021).
Google Scholar
Wang, H. X. et al. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice. Cardiovasc. Res. 115, 83–93 (2019).
Google Scholar
Ong, S., Rose, N. R. & Cihakova, D. Natural killer cells in inflammatory heart disease. Clin. Immunol. 175, 26–33 (2017).
Google Scholar
Bouchentouf, M. et al. Induction of cardiac angiogenesis requires killer cell lectin-like receptor 1 and alpha4beta7 integrin expression by NK cells. J. Immunol. 185, 7014–7025 (2010).
Google Scholar
Bouvain, P. et al. Non-invasive mapping of systemic neutrophil dynamics upon cardiovascular injury. Nat. Cardiovasc. Res. 2, 126–143 (2023).
Google Scholar
Phillipson, M. & Kubes, P. The neutrophil in vascular inflammation. Nat. Med. 17, 1381–1390 (2011).
Google Scholar
Ofori, E. A. et al. Human blood neutrophils generate ROS through FcgammaR-signaling to mediate protection against febrile P. falciparum malaria. Commun. Biol. 6, 743 (2023).
Google Scholar
Malamud, M. et al. Recognition and control of neutrophil extracellular trap formation by MICL. Nature 633, 442–450 (2024).
Google Scholar
Cowan, K. N., Jones, P. L. & Rabinovitch, M. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease. J. Clin. Investig. 105, 21–34 (2000).
Google Scholar
Christoffersson, G. et al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 120, 4653–4662 (2012).
Google Scholar
Kim, C., et al. Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy. Nat. Commun. 15, 8481 (2024).
Google Scholar
Dao Nyesiga, G., et al. Tolerogenic dendritic cells generated in vitro using a novel protocol mimicking mucosal tolerance mechanisms represent a potential therapeutic cell platform for induction of immune tolerance. Front. Immunol. 14, 1045183 (2023).
Google Scholar
Forte, E. et al. Cross-priming dendritic cells exacerbate immunopathology after ischemic tissue damage in the heart. Circulation 143, 821–836 (2021).
Google Scholar
Ma, Y. et al. Efferocytosis in dendritic cells: an overlooked immunoregulatory process. Front. Immunol. 15, 1415573 (2024).
Google Scholar
Nayer, B., et al. Local administration of regulatory T cells promotes tissue healing. Nat. Commun. 15, 7863 (2024).
Google Scholar
Blanton, R. M., Carrillo-Salinas, F. J. & Alcaide, P. T-cell recruitment to the heart: friendly guests or unwelcome visitors?. Am. J. Physiol. Heart Circ. Physiol. 317, H124–H140 (2019).
Google Scholar
Huang, F. et al. B cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion. JCI Insight. 9, (2024).
Porsch, F., Mallat, Z. & Binder, C. J. Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. Cardiovasc. Res. 117, 2544–2562 (2021).
Google Scholar
Garcia-Rivas, G. et al. The role of B cells in heart failure and implications for future immunomodulatory treatment strategies. ESC Heart Fail. 7, 1387–1399 (2020).
Google Scholar
Becker, N. P., Goettel, P., Mueller, J., Wallukat, G. & Schimke, I. Functional autoantibody diseases: Basics and treatment related to cardiomyopathies. Front. Biosci.24, 48–95 (2019).
Google Scholar
Jiao, J. et al. Regulatory B cells improve ventricular remodeling after myocardial infarction by modulating monocyte migration. Basic Res. Cardiol. 116, 46 (2021).
Google Scholar
Tan, Y. et al. Murine neonatal cardiac B cells promote cardiomyocyte proliferation and heart regeneration. NPJ Regen. Med. 8, 7 (2023).
Google Scholar
Bermea, K. C. et al. Myocardial B cells have specific gene expression and predicted interactions in dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy. Front. Immunol. 15, 1327372 (2024).
Google Scholar
Oduro, P. K. et al. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. Acta Pharmacol. Sin. B 12, 50–75 (2022).
Google Scholar
Bullen, C. K. et al. MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival. JCI Insight 8, e166242 (2023).
Google Scholar
Caneparo, V., Landolfo, S., Gariglio, M. & De Andrea, M. The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: the dark side of sensing microbes. Front. Immunol. 9, 1180 (2018).
Google Scholar
Doran, A. C., Yurdagul, A. Jr. & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254–267 (2020).
Google Scholar
Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907–917 (2015).
Google Scholar
Wang, X. et al. Targeting regulatory T cells for cardiovascular diseases. Front. Immunol. 14, 1126761 (2023).
Google Scholar
Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523–532 (2008).
Google Scholar
Zhang, N. et al. The role of apoptosis in the development and function of T lymphocytes. Cell Res. 15, 749–769 (2005).
Google Scholar
Holodick, N. E., Rodriguez-Zhurbenko, N. & Hernandez, A. M. Defining natural antibodies. Front. Immunol. 8, 872 (2017).
Google Scholar
Harris, E. Majority of People Live With Uncontrolled Hypertension Worldwide. JAMA 330, 1515 (2023).
Google Scholar
Wen, X. et al. The Minhang Pediatric Biobank cohort study: protocol overview and baseline characteristics. BMC Pediatr. 24, 282 (2024).
Google Scholar
Schutte, A. E. et al. Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension. Cardiovasc. Res. 119, 381–409 (2023).
Google Scholar
NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 398, 957–980 (2021).
Google Scholar
Evangelou, E. et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat. Genet. 50, 1412–1425 (2018).
Google Scholar
Garshick, M. S., Ward, N. L., Krueger, J. G. & Berger, J. S. Cardiovascular risk in patients with psoriasis: JACC review topic of the week. J. Am. Coll. Cardiol. 77, 1670–1680 (2021).
Google Scholar
Panoulas, V. F. et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology 46, 1477–1482 (2007).
Google Scholar
Munoz Aguilera, E. et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc. Res. 116, 28–39 (2020).
Google Scholar
Eke, P. I. et al. Periodontitis in US Adults: National health and nutrition examination survey 2009-2014. J. Am. Dent. Assoc. 149, 576–588.e576 (2018).
Google Scholar
Meng, X. et al. Regulatory T cells in cardiovascular diseases. Nat. Rev. Cardiol. 13, 167–179 (2016).
Google Scholar
Xia, Y., et al. Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets. Front. Immunol. 15, 1331609 (2024).
Google Scholar
Guzik, T. J., Nosalski, R., Maffia, P. & Drummond, G. R. Immune and inflammatory mechanisms in hypertension. Nat. Rev. Cardiol. 21, 396–416 (2024).
Google Scholar
Steinman, R. M., Hawiger, D. & Nussenzweig, M. C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685–711 (2003).
Google Scholar
Higaki, A. & Mogi, M. Dendritic cells as potential initiators of immune-mediated hypertensive disorders. Hypertens. Res. 45, 527–529 (2021).
Google Scholar
Barbaro, N. R. et al. Dendritic cell amiloride-sensitive channels mediate sodium-induced inflammation and hypertension. Cell Rep. 21, 1009–1020 (2017).
Google Scholar
Carnevale, D., et al. A cholinergic-sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat. Commun. 7, 13035 (2016).
Google Scholar
Pavlov, V. A. & Tracey, K. J. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat. Neurosci. 20, 156–166 (2017).
Google Scholar
Nguyen, B. A., Alexander, M. R. & Harrison, D. G. Immune mechanisms in the pathophysiology of hypertension. Nat. Rev. Nephrol. 20, 530–540 (2024).
Google Scholar
Hahn, C. & Schwartz, M. A. Mechanotransduction in vascular physiology and atherogenesis. Nat. Rev. Mol. Cell Biol. 10, 53–62 (2009).
Google Scholar
Harrison, D. G. & Patrick, D. M. Immune mechanisms in hypertension. Hypertension 81, 1659–1674 (2024).
Google Scholar
Itani, H. A. et al. Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans. Hypertension 68, 123–132 (2016).
Google Scholar
Wang, X., et al. Single-cell transcriptome profiling reveals enriched memory T-cell subpopulations in hypertension. Front. Cell Dev. Biol. 11, 1132040 (2023).
Google Scholar
Pober, J. S., Merola, J., Liu, R. & Manes, T. D. Antigen presentation by vascular cells. Front. Immunol. 8, 1907 (2017).
Google Scholar
Didion, S. P. et al. Endogenous interleukin-10 inhibits angiotensin II-induced vascular dysfunction. Hypertension 54, 619–624 (2009).
Google Scholar
Libby, P. Inflammation in atherosclerosis. Nature 420, 868–874 (2002).
Google Scholar
Trimm, E. & Red-Horse, K. Vascular endothelial cell development and diversity. Nat. Rev. Cardiol. 20, 197–210 (2023).
Google Scholar
Neubauer, K. & Zieger, B. Endothelial cells and coagulation. Cell Tissue Res. 387, 391–398 (2022).
Google Scholar
Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat. Rev. Immunol. 7, 803–815 (2007).
Google Scholar
He, C. et al. The role of immune cells in different stages of atherosclerosis. Int. J. Med. Sci. 21, 1129–1143 (2024).
Google Scholar
Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat. Immunol. 12, 204–212 (2011).
Google Scholar
Zernecke, A. et al. Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas. Circ. Res. 127, 402–426 (2020).
Google Scholar
Pan, H. et al. Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human. Circulation 142, 2060–2075 (2020).
Google Scholar
Wirka, R. C. et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat. Med. 25, 1280–1289 (2019).
Google Scholar
Feil, S. et al. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis. Circ. Res. 115, 662–667 (2014).
Google Scholar
Libby, P. The changing landscape of atherosclerosis. Nature 592, 524–533 (2021).
Google Scholar
Bairey Merz, C. N., Pepine, C. J., Walsh, M. N. & Fleg, J. L. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation 135, 1075–1092 (2017).
Google Scholar
Nishimiya, K. et al. Mechanisms of coronary artery spasm. Eur. Cardiol. 18, e39 (2023).
Google Scholar
Mensah, G. A. et al. Global burden of cardiovascular diseases and risks, 1990-2022. J. Am. Coll. Cardiol. 82, 2350–2473 (2023).
Google Scholar
Dittrich, A. & Lauridsen, H. Myocardial infarction and the immune response – Scarring or regeneration? A comparative look at mammals and popular regenerating animal models. J. Immunol. Regen. Med. 4, 100016 (2019).
Santos-Zas, I., Lemarie, J., Tedgui, A. & Ait-Oufella, H. Adaptive immune responses contribute to post-ischemic cardiac remodeling. Front. Cardiovasc. Med. 5, 198 (2018).
Google Scholar
Xu, S. W., Xu, C., Xu, J. H., Zhang, K. & Zhang, H. J. Macrophage heterogeneity and its impact on myocardial ischemia-reperfusion injury: an integrative review. J. Inflamm. Res. 16, 5971–5987 (2023).
Google Scholar
Zouggari, Y. et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 19, 1273–1280 (2013).
Google Scholar
Feng, Q., et al. The role of major immune cells in myocardial infarction. Front. Immunol. 13, 1084460 (2022).
Google Scholar
Tang, T. T. et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res. Cardiol. 107, 232 (2012).
Google Scholar
Kumar, V., Prabhu, S. D. & Bansal, S. S. CD4(+) T-lymphocytes exhibit biphasic kinetics post-myocardial infarction. Front. Cardiovasc. Med. 9, 992653 (2022).
Google Scholar
Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387–407 (2018).
Google Scholar
Frantz, S. et al. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur. Heart J. 43, 2549–2561 (2022).
Google Scholar
Robson, P. M. et al. MR/PET imaging of the cardiovascular system. JACC Cardiovasc. Imaging 10, 1165–1179 (2017).
Google Scholar
Barros-Gomes, S. et al. Cardiac remodeling in acute myocardial infarction: Prospective insights from multimodality ultrasound imaging. Echocardiography 38, 2032–2042 (2021).
Google Scholar
Martinez, M. W. et al. Exercise-induced cardiovascular adaptations and approach to exercise and cardiovascular disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 78, 1453–1470 (2021).
Google Scholar
De Haas, S. et al. Cardiac remodeling in normotensive pregnancy and in pregnancy complicated by hypertension: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 50, 683–696 (2017).
Google Scholar
Deb, A. & Ubil, E. Cardiac fibroblast in development and wound healing. J. Mol. Cell Cardiol. 70, 47–55 (2014).
Google Scholar
Jitmana, R. et al. Role of cardiac mast cells in exercise training-mediated cardiac remodeling in angiotensin II-infused ovariectomized rats. Life Sci. 219, 209–218 (2019).
Google Scholar
Lavine, K. J. et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl. Acad. Sci. USA 111, 16029–16034 (2014).
Google Scholar
Wang, Z. et al. Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling. Proc. Natl. Acad. Sci. USA 116, 18455–18465 (2019).
Google Scholar
Borges, D. et al. Exercise training and cardiac remodeling sports, health and exercise medicine. Exerc. Sport Sci. Rev. 50, 137–144 (2019).
Yin, A., et al. Exercise-derived peptide protects against pathological cardiac remodeling. EBioMedicine 82, 104164 (2022).
Google Scholar
Du, H. et al. Tuning immunity through tissue mechanotransduction. Nat. Rev. Immunol. 23, 174–188 (2023).
Google Scholar
Yap, J. et al. Macrophages in cardiac remodelling after myocardial infarction. Nat. Rev. Cardiol. 20, 373–385 (2023).
Google Scholar
Nian, M., Lee, P., Khaper, N. & Liu, P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 94, 1543–1553 (2004).
Google Scholar
Strassheim, D., et al. Role of inflammatory cell subtypes in heart Failure. J. Immunol. Res. 2019, 2164017 (2019).
Google Scholar
Kologrivova, I., Shtatolkina, M., Suslova, T. & Ryabov, V. Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction. Front. Immunol. 12, 664457 (2021).
Google Scholar
De Angelis, E. et al. Cross-talk between neurohormonal pathways and the immune system in heart failure: a review of the literature. Int. J. Mol. Sci. 20, 1698 (2019).
Nishida, K. & Otsu, K. Inflammation and metabolic cardiomyopathy. Cardiovasc. Res. 113, 389–398 (2017).
Google Scholar
Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860–867 (2006).
Google Scholar
Wellen, K. E. Inflammation, stress, and diabetes. J. Clin. Investig. 115, 1111–1119 (2005).
Google Scholar
Bahrar, H. et al. Innate immune memory in cardiometabolic disease. Cardiovasc. Res. 119, 2774–2786 (2024).
Google Scholar
Jia, G. et al. Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet. Hypertension 65, 531–539 (2015).
Google Scholar
Eguchi, K. & Nagai, R. Islet inflammation in type 2 diabetes and physiology. J. Clin. Investig. 127, 14–23 (2017).
Google Scholar
Knapp, M., Tu, X. & Wu, R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol. Sin. 40, 1–8 (2019).
Google Scholar
Abumrad, N. A. et al. Endothelial cell receptors in tissue lipid uptake and metabolism. Circ. Res. 128, 433–450 (2021).
Google Scholar
Zhang, Y. et al. Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-beta signaling. Theranostics 12, 7250–7266 (2022).
Google Scholar
Ballasy, N. N., et al. Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes. FASEB J. 35, e21878 (2021).
Google Scholar
Wegner, M., Neddermann, D., Piorunska-Stolzmann, M. & Jagodzinski, P. P. Role of epigenetic mechanisms in the development of chronic complications of diabetes. Diabetes Res. Clin. Pr. 105, 164–175 (2014).
Google Scholar
Kenny, H. C. & Abel, E. D. Heart failure in type 2 diabetes mellitus. Circ. Res. 124, 121–141 (2019).
Google Scholar
Isselbacher, E. M. et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 146, e334–e482 (2022).
Cho, M. J., Lee, M. R. & Park, J. G. Aortic aneurysms: current pathogenesis and therapeutic targets. Exp. Mol. Med. 55, 2519–2530 (2023).
Google Scholar
Zhao, G. et al. Single-cell RNA sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta. Cardiovasc. Res. 117, 1402–1416 (2021).
Google Scholar
Li, Y. et al. Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue. Circulation 142, 1374–1388 (2020).
Google Scholar
Smigiel, K. S., Srivastava, S., Stolley, J. M. & Campbell, D. J. Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation. Immunol. Rev. 259, 40–59 (2014).
Google Scholar
Dri, E. et al. Inflammatory mediators of endothelial dysfunction. Life. 13, 1420 (2023).
Bobryshev, Y. V. Dendritic cells and their role in atherogenesis. Lab Investig. 90, 970–984 (2010).
Google Scholar
Meng, Q. et al. Laminar shear stress inhibits inflammation by activating autophagy in human aortic endothelial cells through HMGB1 nuclear translocation. Commun. Biol. 5, 425 (2022).
Google Scholar
Xue, Y. et al. Macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through IL-1beta/STAT3 signaling. Commun. Biol. 5, 1316 (2022).
Google Scholar
Kenney, M. J. & Ganta, C. K. Autonomic nervous system and immune system interactions. Compr. Physiol. 4, 1177–1200 (2014).
Google Scholar
Yuan, Z. et al. Abdominal aortic aneurysm: roles of inflammatory cells. Front. Immunol. 11, 609161 (2020).
Google Scholar
Davis, F. M. & Gallagher, K. A. Epigenetic mechanisms in monocytes/macrophages regulate inflammation in cardiometabolic and vascular disease. Arterioscler Thromb. Vasc. Biol. 39, 623–634 (2019).
Google Scholar
Hernandez, G. E. et al. Aortic intimal resident macrophages are essential for maintenance of the non-thrombogenic intravascular state. Nat. Cardiovasc. Res. 1, 67–84 (2022).
Google Scholar
Choi, J. H. et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206, 497–505 (2009).
Google Scholar
Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
Google Scholar
Ma-Krupa, W. et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J. Exp. Med. 199, 173–183 (2004).
Google Scholar
Jauhiainen, S., Kiema, M., Hedman, M. & Laakkonen, J. P. Large Vessel Cell Heterogeneity and plasticity: focus in aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 42, 811–818 (2022).
Google Scholar
Li, J., et al. Aorta regulatory T cells with a tissue-specific phenotype and function promote tissue repair through Tff1 in abdominal aortic aneurysms. Adv. Sci. 9, e2104338 (2022).
Google Scholar
Luan, Y. et al. Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets. Cell Death Discov. 10, 78 (2024).
Google Scholar
Desdín-Micó, G. et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368, 1371–1376 (2020).
Google Scholar
Faust, H. J. et al. IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis. J. Clin. Investig. 130, 5493–5507 (2020).
Google Scholar
Ovadya, Y., et al. Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat. Commun. 9, 5435 (2018).
Google Scholar
Elyahu, Y., et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci. Adv. 5, eaaw8330 (2019).
Google Scholar
Pereira, B. I. et al. Sestrins induce natural killer function in senescent-like CD8(+) T cells. Nat. Immunol. 21, 684–694 (2020).
Google Scholar
Tang, X., Li, P. H. & Chen, H. Z. Cardiomyocyte senescence and cellular communications within myocardial microenvironments. Front. Endocrinol.11, 280 (2020).
Google Scholar
He, A. & Shi, G. P. Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases. Curr. Pharmacol. Des. 19, 1114–1125 (2013).
Google Scholar
Grim, J. C. et al. Secreted factors from proinflammatory macrophages promote an osteoblast-like phenotype in valvular interstitial cells. Arterioscler. Thromb. Vasc. Biol. 40, e296–e308 (2020).
Google Scholar
Bloom, S. I., Islam, M. T., Lesniewski, L. A. & Donato, A. J. Mechanisms and consequences of endothelial cell senescence. Nat. Rev. Cardiol. 20, 38–51 (2023).
Google Scholar
Gardner, S. E., Humphry, M., Bennett, M. R. & Clarke, M. C. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype. Arterioscler. Thromb. Vasc. Biol. 35, 1963–1974 (2015).
Google Scholar
Grune, J., Yamazoe, M. & Nahrendorf, M. Electroimmunology and cardiac arrhythmia. Nat. Rev. Cardiol. 18, 547–564 (2021).
Google Scholar
Baksi, A. J., Kanaganayagam, G. S. & Prasad, S. K. Arrhythmias in viral myocarditis and pericarditis. Card. Electrophysiol. Clin. 7, 269–281 (2015).
Google Scholar
Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801 (2016).
Google Scholar
Dobrev, D. et al. Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. Nat. Rev. Cardiol. 20, 145–167 (2023).
Google Scholar
Lazzerini, P. E. et al. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat. Rev. Immunol. 19, 63–64 (2019).
Google Scholar
Xiao, G. Q., Hu, K. & Boutjdir, M. Direct inhibition of expressed cardiac L- and T-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation 103, 1599–1604 (2001).
Google Scholar
Karnabi, E. et al. Congenital heart block: identification of autoantibody binding site on the extracellular loop (domain I, S5-S6) of α1D L-type Ca channel. J. Autoimmun. 34, 80–86 (2010).
Google Scholar
Lazzerini, P. E. et al. Anti-Ro/SSA antibodies blocking calcium channels as a potentially reversible cause of atrioventricular block in adults. JACC Clin. Electrophysiol. 9, 1631–1648 (2023).
Google Scholar
Sethi, N. et al. Noninvasive fetal electrocardiography in the diagnosis of long QT syndrome: a case series. Fetal Diagn. Ther. 47, 711–716 (2020).
Google Scholar
Yue, Y., Casadei, B. & Marín-García, J. Pathogenesis of the novel autoimmune-associated long-QT syndrome. Circulation 132, 230–240 (2015).
Google Scholar
Lazzerini, P. E., et al. Arrhythmogenicity of anti-Ro/SSA antibodies in patients with torsades de pointes. Circ. Arrhythm. Electrophysiol. 9, e003419 (2016).
Google Scholar
Suzuki, S. et al. Cardiac involvements in myasthenia gravis associated with anti-KV1.4 antibodies. Eur. J. Neurol. 21, 223–230 (2014).
Google Scholar
Li, J. et al. Anti-KCNQ1 K channel autoantibodies increase IKs current and are associated with QT interval shortening in dilated cardiomyopathy. Cardiovasc. Res. 98, 496–503 (2013).
Google Scholar
Pollack, A., Kontorovich, A. R., Fuster, V. & Dec, G. W. Viral myocarditis-diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 12, 670–680 (2015).
Google Scholar
Tschöpe, C. et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat. Rev. Cardiol. 18, 169–193 (2021).
Google Scholar
Koc, A. & Cagavi, E. Cardiac immunology: a new era for immune cells in the heart. Adv. Exp. Med. Biol. 1312, 75–95 (2021).
Google Scholar
Fang, M. et al. TRIM18 is a critical regulator of viral myocarditis and organ inflammation. J. Biomed. Sci. 29, 55 (2022).
Google Scholar
Wang, J., et al. Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice. Nat. Commun. 15, 3481 (2024).
Google Scholar
Pappritz, K. et al. Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis. FASEB J. 32, 6066–6078 (2018).
Google Scholar
Dubin, K., et al. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat. Commun. 7, 10391 (2016).
Google Scholar
Kindermann, I. et al. Update on myocarditis. J. Am. Coll. Cardiol. 59, 779–792 (2012).
Google Scholar
Sury, K., Perazella, M. A. & Shirali, A. C. Cardiorenal complications of immune checkpoint inhibitors. Nat. Rev. Nephrol. 14, 571–588 (2018).
Google Scholar
Wang, S. et al. Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors. BMC Med. 19, 140 (2021).
Google Scholar
Kantarjian, H. et al. Blinatumomab versus chemotherapy for Advanced Acute Lymphoblastic Leukemia. N. Engl. J. Med. 376, 836–847 (2017).
Google Scholar
Grupp, S. A. et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368, 1509–1518 (2013).
Google Scholar
Cameron, B. J. et al. Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells. Sci. Transl. Med. 5, ra103 (2013).
Google Scholar
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharm. Rev. 56, 185–229 (2004).
Google Scholar
Bhagat, A., Shrestha, P. & Kleinerman, E. S. The innate immunesystem in cardiovascular diseases and Its role in doxorubicin-induced cardiotoxicity. Int. J. Mol. Sci. 23, 14649 (2022).
Google Scholar
Bayer, A. L. et al. Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction. Nat. Cardiovasc. Res. 3, 970–986 (2024).
Google Scholar
Xi, Y. et al. Triptolide induces p53-dependent cardiotoxicity through mitochondrial membrane permeabilization in cardiomyocytes. Toxicol. Appl. Pharmacol. 355, 269–285 (2018).
Google Scholar
Wang, S. R. et al. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats. Biomed. Pharmacother. 111, 1467–1477 (2019).
Google Scholar
Dent, S. F., Morse, A., Burnette, S., Guha, A. & Moore, H. Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer. Curr. Oncol. Rep. 23, 128 (2021).
Google Scholar
Mahalingaiah, P. K. et al. Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates. Pharm. Ther. 200, 110–125 (2019).
Google Scholar
Ho, R. J. & Chien, J. Trends in translational medicine and drug targeting and delivery: new insights on an old concept-targeted drug delivery with antibody-drug conjugates for cancers. J. Pharm. Sci. 103, 71–77 (2014).
Google Scholar
Behrens, G. M. & Reiss, P. Abacavir and cardiovascular risk. Curr. Opin. Infect. Dis. 23, 9–14 (2010).
Google Scholar
Fresse, A. et al. Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem. Int. J. Cardiol. 324, 255–260 (2021).
Google Scholar
Marzolini, C. et al. Effect of systemic inflammatory response to SARS-CoV-2 on lopinavir and hydroxychloroquine plasma concentrations. Antimicrob. Agents Chemother. 64, e01177–01120 (2020).
Google Scholar
Durrington, C. et al. Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry. Eur. Respir. J. 63, 2300846 (2024).
Google Scholar
Kang, Y. H. et al. Complement-coagulation cross-talk:factor H-mediated regulation of the complement classical pathway activation by fibrin clots. Front. Immunol. 15, 1368852 (2024).
Google Scholar
Stark, K. & Massberg, S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 18, 666–682 (2021).
Google Scholar
Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34–45 (2013).
Google Scholar
Renne, T. & Stavrou, E. X. Roles of factor XII in innate immunity. Front. Immunol. 10, 2011 (2019).
Google Scholar
Kale, S. et al. The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS ONE 5, e13852 (2010).
Google Scholar
Michels, E. H. A., et al. Association between age and the host response in critically ill patients with sepsis. Crit. Care 26, 385 (2022).
Google Scholar
Jackson, S. P. Arterial thrombosis-insidious, unpredictable and deadly. Nat. Med. 17, 1423–1436 (2011).
Google Scholar
Massberg, S. et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J. Exp. Med. 196, 887–896 (2002).
Google Scholar
Massberg, S. et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112, 1180–1188 (2005).
Google Scholar
Gerdes, N. et al. Platelet CD40 exacerbates atherosclerosis by transcellular activation of endothelial cells and leukocytes. Arterioscler Thromb. Vasc. Biol. 36, 482–490 (2016).
Google Scholar
Drechsler, M. et al. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 122, 1837–1845 (2010).
Google Scholar
Koenen, R. R. et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15, 97–103 (2009).
Google Scholar
Massberg, S. et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J. Exp. Med. 203, 1221–1233 (2006).
Google Scholar
Gaertner, F. et al. Migrating platelets are mechano-scavengers that collect and bundle bacteria. Cell 171, 1368–1382.e1323 (2017).
Google Scholar
Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight 5, e138999 (2020).
Google Scholar
Martinod, K. et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl. Acad. Sci. USA 110, 8674–8679 (2013).
Google Scholar
Li, P. et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853–1862 (2010).
Google Scholar
Stark, K. et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435–2449 (2016).
Google Scholar
Jaen, R. I. et al. Innate immune receptors, key actors in cardiovascular diseases. JACC Basic Transl. Sci. 5, 735–749 (2020).
Google Scholar
Fernandez-Ruiz, I. Immune system and cardiovascular disease. Nat. Rev. Cardiol. 13, 503 (2016).
Google Scholar
Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997).
Google Scholar
Liu, T., Liu, S. & Zhou, X. Innate immune responses and pulmonary diseases. Adv. Exp. Med. Biol. 1304, 53–71 (2021).
Google Scholar
Ionita, M. G., Arslan, F., de Kleijn, D. P. & Pasterkamp, G. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease. J. Innate Immun. 2, 307–315 (2010).
Google Scholar
Steinberg, D. & Witztum, J. L. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb. Vasc. Biol. 30, 2311–2316 (2010).
Google Scholar
Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783–801 (2006).
Google Scholar
Lin, S. C., Lo, Y. C. & Wu, H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465, 885–890 (2010).
Google Scholar
Motshwene, P. G. et al. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J. Biol. Chem. 284, 25404–25411 (2009).
Google Scholar
Kollewe, C. et al. Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. J. Biol. Chem. 279, 5227–5236 (2004).
Google Scholar
Verstak, B. et al. The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4. J. Leukoc. Biol. 96, 427–436 (2014).
Google Scholar
Hu, L., et al. Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity. Nat. Commun. 8, 814 (2017).
Google Scholar
Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of immunity. Cell 180, 1044–1066 (2020).
Google Scholar
McWhirter, S. M. et al. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101, 233–238 (2004).
Google Scholar
Sharma, S. et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148–1151 (2003).
Google Scholar
Liu, T. et al. Gasdermin B, an asthma-susceptibility gene, promotes MAVS-TBK1 signalling and airway inflammation. Eur. Respir. J. 63, 2301232 (2024).
Google Scholar
Nishimura, M. & Naito, S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol. Pharmacol. Bull. 28, 886–892 (2005).
Google Scholar
Liu, L. et al. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J. Cell Mol. Med. 19, 2728–2740 (2015).
Google Scholar
Oyama, J. et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109, 784–789 (2004).
Google Scholar
Shimamoto, A. et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 114, I270–274 (2006).
Google Scholar
Shishido, T. et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108, 2905–2910 (2003).
Google Scholar
Frantz, S. et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Investig. 104, 271–280 (1999).
Google Scholar
Liu, Y. Y. et al. Bacillus Calmette-Guérin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment. J. Immunol. 180, 7349–7357 (2008).
Google Scholar
Gao, W., Xiong, Y., Li, Q. & Yang, H. Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics. Front. Physiol. 8, 508 (2017).
Google Scholar
Yeh, F. C. et al. TLR7/8 activation induces autoimmune vasculopathy and causes severe pulmonary arterial hypertension. Eur. Respir. J. 62, 2300204 (2023).
Google Scholar
Levitan, I., Volkov, S. & Subbaiah, P. V. Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid. Redox Signal. 13, 39–75 (2010).
Google Scholar
Edfeldt, K., Swedenborg, J., Hansson, G. K. & Yan, Z. Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105, 1158–1161 (2002).
Google Scholar
Singh, R. K. et al. TLR4 (Toll-Like Receptor 4)-dependent signaling drives extracellular catabolism of LDL (Low-Density Lipoprotein) aggregates. Arterioscler Thromb. Vasc. Biol. 40, 86–102 (2020).
Google Scholar
Lee, G. L. et al. TLR2 promotes vascular smooth muscle cell chondrogenic differentiation and consequent calcification via the concerted actions of 0steoprotegerin suppression and IL-6-mediated RANKL induction. Arterioscler Thromb. Vasc. Biol. 39, 432–445 (2019).
Google Scholar
Sundaram, B., Tweedell, R. E., Prasanth Kumar, S. & Kanneganti, T. D. The NLR family of innate immune and cell death sensors. Immunity 57, 674–699 (2024).
Google Scholar
Liu, T. et al. USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy. Cell Mol. Immunol. 18, 2431–2442 (2021).
Google Scholar
Liu, T. et al. NOD-like receptor family, pyrin domain containing 3 (NLRP3) contributes to inflammation, pyroptosis, and mucin production in human airway epithelium on rhinovirus infection. J. Allergy Clin. Immunol. 144, 777–787.e9 (2019).
Google Scholar
Sundaram, B. et al. NLRC5 senses NAD(+) depletion, forming a PANoptosome and driving PANoptosis and inflammation. Cell 187, 4061–4077.E17 (2024).
Google Scholar
Sundaram, B. et al. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell 186, 2783–2801.e20 (2023).
Google Scholar
Nakamura, N. et al. Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509, 240–244 (2014).
Google Scholar
Girardin, S. E. et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584–1587 (2003).
Google Scholar
Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869–8872 (2003).
Google Scholar
Caruso, R., Warner, N., Inohara, N. & Núñez, G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity 41, 898–908 (2014).
Google Scholar
Inohara, N. et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274, 14560–14567 (1999).
Google Scholar
Ogura, Y. et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276, 4812–4818 (2001).
Google Scholar
Sorbara, M. T. et al. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner. Immunity 39, 858–873 (2013).
Google Scholar
Yeretssian, G. et al. Non-apoptotic role of BID in inflammation and innate immunity. Nature 474, 96–99 (2011).
Google Scholar
Alvarez-Simon, D. et al. Local Receptor-interacting Protein Kinase 2 inhibition mitigates HDM-induced asthma. Eur. Respir. J. 64, 2302288 (2024).
Google Scholar
Watanabe, T. et al. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Investig. 120, 1645–1662 (2010).
Google Scholar
Bauernfeind, F. G. et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787–791 (2009).
Google Scholar
Xing, Y. et al. Cutting edge: TRAF6 mediates TLR/IL-1R signaling-induced nontranscriptional priming of the NLRP3 inflammasome. J. Immunol. 199, 1561–1566 (2017).
Google Scholar
Juliana, C. et al. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 287, 36617–36622 (2012).
Google Scholar
Py, B. F., Kim, M. S., Vakifahmetoglu-Norberg, H. & Yuan, J. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol. Cell 49, 331–338 (2013).
Google Scholar
Song, H., et al. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat. Commun. 7, 13727 (2016).
Google Scholar
Masumoto, J. et al. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274, 33835–33838 (1999).
Google Scholar
Ramos-Junior, E. S. & Morandini, A. C. Gasdermin: a new player to the inflammasome game. Biomed. J. 40, 313–316 (2017).
Google Scholar
He, Y. et al. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354–357 (2016).
Google Scholar
Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17, 250–258 (2016).
Google Scholar
Zhou, L. et al. Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease development. J. Allergy Clin. Immunol. 147, 267–279 (2021).
Google Scholar
Liu, T., Woodruff, P. G. & Zhou, X. Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies. Eur. Respir. J. 64, 2300826 (2024).
Google Scholar
Perea, L. et al. Airway IL-1β is related to disease severity and mucociliary function in bronchiectasis. Eur. Respir. J. 64, 2301966 (2024).
Google Scholar
Wu, C. H. et al. NLR network mediates immunity to diverse plant pathogens. Proc. Natl. Acad. Sci. USA 114, 8113–8118 (2017).
Google Scholar
Kuriakose, T. et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci. Immunol. 1, aag2045 (2016).
Google Scholar
Christgen, S. et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front. Cell Infect. Microbiol 10, 237 (2020).
Google Scholar
Yang, H. et al. Activation of NOD1 by DAP contributes to myocardial ischemia/reperfusion injury via multiple signaling pathways. Apoptosis 20, 512–522 (2015).
Google Scholar
Val-Blasco, A. et al. NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes. Biochem. J. 474, 399–410 (2017).
Google Scholar
Shen, L. et al. Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model. Int. J. Mol. Med. 42, 3017–3026 (2018).
Google Scholar
Zong, J. et al. NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload. Lab Investig. 93, 1128–1136 (2013).
Google Scholar
Kanno, S. et al. Activation of an innate immune receptor, Nod1, accelerates atherogenesis in Apoe-/- mice. J. Immunol. 194, 773–780 (2015).
Google Scholar
Johansson, M. E. et al. Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice. Eur. J. Immunol. 44, 3081–3092 (2014).
Google Scholar
Yuan, H. et al. Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss. Proc. Natl. Acad. Sci. USA 110, E5059–E5068 (2013).
Google Scholar
Liu, H. Q. et al. NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arterioscler Thromb. Vasc. Biol. 33, 2193–2201 (2013).
Google Scholar
Kim, H. et al. A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation. Sci. Rep. 5, 12018 (2015).
Google Scholar
Kim, H. J. Role of nucleotide-binding and oligomerization domain 2 protein (NOD2) in the development of atherosclerosis. Korean J. Physiol. Pharmacol. 19, 479–484 (2015).
Google Scholar
Liu, Y. et al. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res. Cardiol. 109, 415 (2014).
Google Scholar
van Hout, G. P. et al. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction. Eur. Heart J. 38, 828–836 (2017).
Google Scholar
Toldo, S. & Abbate, A. The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Nat. Rev. Cardiol. 21, 219–237 (2024).
Google Scholar
Kawaguchi, M. et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123, 594–604 (2011).
Google Scholar
Li, X. et al. TAK1 Activation by NLRP3 Deficiency Confers Cardioprotection Against Pressure Overload-Induced Cardiomyocyte Pyroptosis and Hypertrophy. JACC Basic Transl. Sci. 8, 1555–1573 (2023).
Google Scholar
Li, J. et al. Landscape of RNA-binding proteins in diagnostic utility, immune cell infiltration and PANoptosis features of heart failure. Front. Genet 13, 1004163 (2022).
Google Scholar
Bi, Y., et al. FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM. Cell Death Dis. 13, 1020 (2022).
Google Scholar
Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).
Google Scholar
Yin, R. et al. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice. Ann. Palliat. Med. 8, 676–689 (2019).
Google Scholar
Li, W. et al. Humanin ameliorates free fatty acid-induced endothelial inflammation by suppressing the NLRP3 inflammasome. ACS Omega 5, 22039–22045 (2020).
Google Scholar
Bai, Y. et al. circACTA2 inhibits NLRP3 inflammasome-mediated inflammation via interacting with NF-κB in vascular smooth muscle cells. Cell Mol. Life Sci. 80, 229 (2023).
Google Scholar
Guo, S. et al. Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis. Cardiovasc. Res. 120, 883–898 (2024).
Google Scholar
Batool, M., Kim, M. S. & Choi, S. Structural insights into the distinctive RNA recognition and therapeutic potentials of RIG-I-like receptors. Med. Res. Rev. 42, 399–425 (2022).
Google Scholar
Ferrage, F. et al. Structure and dynamics of the second CARD of human RIG-I provide mechanistic insights into regulation of RIG-I activation. Structure 20, 2048–2061 (2012).
Google Scholar
Satoh, T. et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. USA 107, 1512–1517 (2010).
Google Scholar
Tang, X. et al. PARP9 is overexpressed in human breast cancer and promotes cancer cell migration. Oncol. Lett. 16, 4073–4077 (2018).
Google Scholar
Camicia, R. et al. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNgamma-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma. J. Cell Sci. 126, 1969–1980 (2013).
Google Scholar
Iwata, H. et al. PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation. Nat. Commun. 7, 12849 (2016).
Google Scholar
Xing, J., et al. Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells. Nat. Commun. 12, 2681 (2021).
Google Scholar
Hornung, V. et al. 5’-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006).
Google Scholar
Myong, S. et al. Cytosolic viral sensor RIG-I is a 5’-triphosphate-dependent translocase on double-stranded RNA. Science 323, 1070–1074 (2009).
Google Scholar
Hayden, M. S. & Ghosh, S. Signaling to NF-kappaB. Genes Dev. 18, 2195–2224 (2004).
Google Scholar
Zhang, E. et al. Mechanisms involved in controlling RNA virus-induced intestinal inflammation. Cell Mol. Life Sci. 79, 313 (2022).
Google Scholar
Li, Z., Nguyen, T. T. & Valaperti, A. Human cardiac fibroblasts produce pro-inflammatory cytokines upon TLRs and RLRs stimulation. Mol. Cell Biochem. 476, 3241–3252 (2021).
Google Scholar
Yu, P. et al. The function, role and process of DDX58 in heart failure and human cancers. Front. Oncol. 12, 911309 (2022).
Google Scholar
Imaizumi, T. et al. Expression of retinoic acid-inducible gene-I (RIG-I) in macrophages: possible involvement of RIG-I in atherosclerosis. J. Atheroscler. Thromb. 14, 51–55 (2007).
Google Scholar
Xu, S., Jin, T. & Weng, J. Endothelial cells as a key cell type for innate immunity: a focused review on RIG-I signaling pathway. Front. Immunol. 13, 951614 (2022).
Google Scholar
Chen, N. et al. PARP9 affects myocardial function through TGF-beta/Smad axis and pirfenidone. Biomol. Biomed. 24, 1199–1215 (2024).
Google Scholar
Xiao, C. Y. et al. Poly(ADP-Ribose) polymerase promotes cardiac remodeling, contractile failure, and translocation of apoptosis-inducing factor in a murine experimental model of aortic banding and heart failure. J. Pharmacol. Exp. Ther. 312, 891–898 (2005).
Google Scholar
Halmosi, R. et al. PARP inhibition and postinfarction myocardial remodeling. Int. J. Cardiol. 217, S52–S59 (2016).
Google Scholar
Erbel, C. et al. PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels. Eur. J. Med. Res. 16, 367–374 (2011).
Google Scholar
Sun, Z. & Hornung, V. cGAS-STING signaling. Curr. Biol. 32, R730–r734 (2022).
Google Scholar
Hu, M. M. & Shu, H. B. Mitochondrial DNA-triggered innate immune response: mechanisms and diseases. Cell Mol. Immunol. 20, 1403–1412 (2023).
Google Scholar
Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548–569 (2021).
Google Scholar
Zhang, Z. D. et al. Disulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115. Cell Mol. Immunol. 21, 275–291 (2024).
Google Scholar
Liu, T. et al. The asthma risk gene, GSDMB, promotes mitochondrial DNA-induced ISGs expression. J. Respir. Biol. Transl. Med. 1, 10005 (2024).
Google Scholar
Shang, G. et al. Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP. Nature 567, 389–393 (2019).
Google Scholar
Zhang, Z. et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 12, 959–965 (2011).
Google Scholar
Parvatiyar, K. et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 13, 1155–1161 (2012).
Google Scholar
Motani, K., et al. The Golgi-resident protein ACBD3 concentrates STING at ER-Golgi contact sites to drive export from the ER. Cell Rep. 41, 111868 (2022).
Google Scholar
Sun, X. et al. Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production. Cell Mol. Immunol. 21, 738–751 (2024).
Google Scholar
Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674–678 (2008).
Google Scholar
Tanaka, Y. & Chen, Z. J. STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway. Sci. Signal 5, ra20 (2012).
Google Scholar
Lee, K. G. et al. Bruton’s tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response. Cell Rep. 10, 1055–1065 (2015).
Google Scholar
Cao, D. J. et al. Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. Circulation 137, 2613–2634 (2018).
Google Scholar
Lai, L., et al. Plasmacytoid dendritic cells mediate myocardial ischemia/reperfusion injury by secreting type I interferons. J. Am. Heart Assoc. 10, e020754 (2021).
Google Scholar
Hu, D. et al. Cytosolic DNA sensor cGAS plays an essential pathogenetic role in pressure overload-induced heart failure. Am. J. Physiol. Heart Circ. Physiol. 318, H1525–h1537 (2020).
Google Scholar
Luo, W. et al. Critical role of the cGAS-STING pathway in doxorubicin-induced cardiotoxicity. Circ. Res. 132, e223–e242 (2023).
Google Scholar
Hayashi, C. et al. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis 215, 52–59 (2011).
Google Scholar
Olejarz, W., Łacheta, D. & Kubiak-Tomaszewska, G. Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability. Int. J. Mol. Sci. 21, 3946 (2020).
Pham, P. T. et al. STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases. Eur. Heart J. 42, 4336–4348 (2021).
Google Scholar
Cai, D. et al. Balasubramide derivative 3C attenuates atherosclerosis in apolipoprotein E-deficient mice: role of AMPK-STAT1-STING signaling pathway. Aging13, 12160–12178 (2021).
Google Scholar
Kwak, H., Lee, E. & Karki, R. DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects. Immunol. Rev. 329, e13382 (2024).
Google Scholar
Venkat, V., et al. Investigating genes associated with heart failure, atrial fibrillation, and other cardiovascular diseases, and predicting disease using machine learning techniques for translational research and precision medicine. Genomics 115, 110584 (2023).
Google Scholar
Smith, J. R., et al. MEF2A suppresses stress responses that trigger DDX41-dependent IFN production. Cell Rep. 42, 112805 (2023).
Google Scholar
Liu, T. et al. TRIM11 suppresses AIM2 inflammasome by degrading AIM2 via p62-dependent selective autophagy. Cell Rep. 16, 1988–2002 (2016).
Google Scholar
Baran, M., et al. PYHIN protein IFI207 regulates cytokine transcription and IRF7 and contributes to the establishment of K. pneumoniae infection. Cell Rep. 42, 112341 (2023).
Google Scholar
Yu, T. et al. TRIM11 attenuates Treg cell differentiation by p62-selective autophagic degradation of AIM2. Cell Rep. 42, 113231 (2023).
Google Scholar
Zheng, Y. et al. Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1-caspase-1 axis. EMBO J. 37, e99347 (2018).
Google Scholar
Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518 (2009).
Google Scholar
Fernandes-Alnemri, T. et al. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509–513 (2009).
Google Scholar
Kerur, N. et al. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 9, 363–375 (2011).
Google Scholar
Fidler, T. P. et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature 592, 296–301 (2021).
Google Scholar
Onódi, Z. et al. AIM2-driven inflammasome activation in heart failure. Cardiovasc. Res. 117, 2639–2651 (2021).
Google Scholar
Fahrländer, H. [Salazosulfapyridine in pregnancy]. Dtsch Med. Wochenschr. 103, 1429 (1978).
Google Scholar
Zhao, T. et al. Ginsenoside Rd promotes cardiac repair after myocardial infarction by modulating monocytes/macrophages subsets conversion. Drug Des. Devel Ther. 16, 2767–2782 (2022).
Google Scholar
Soehnlein, O. & Tall, A. R. AIMing 2 treat atherosclerosis. Nat. Rev. Cardiol. 19, 567–568 (2022).
Google Scholar
Lüsebrink, E., et al. AIM2 stimulation impairs reendothelialization and promotes the development of atherosclerosis in mice. Front. Cardiovasc. Med. 7, 582482 (2020).
Google Scholar
Pan, J. et al. AIM2 regulates vascular smooth muscle cell migration in atherosclerosis. Biochem. Biophys. Res. Commun. 497, 401–409 (2018).
Google Scholar
Paulin, N. et al. Double-strand DNA sensing Aim2 inflammasome regulates atherosclerotic plaque vulnerability. Circulation 138, 321–323 (2018).
Google Scholar
Ugurlar, D. et al. Structures of C1-IgG1 provide insights into how danger pattern recognition activates complement. Science 359, 794–797 (2018).
Google Scholar
Martin, M., Leffler, J. & Blom, A. M. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J. Biol. Chem. 287, 33733–33744 (2012).
Google Scholar
Leffler, J. et al. Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells. J. Biol. Chem. 285, 3766–3776 (2010).
Google Scholar
Mortensen, S. et al. Structural basis for the function of complement component C4 within the classical and lectin pathways of complement. J. Immunol. 194, 5488–5496 (2015).
Google Scholar
Sharp, T. H. et al. Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b. Proc. Natl. Acad. Sci. USA 116, 11900–11905 (2019).
Google Scholar
Zarantonello, A., Revel, M., Grunenwald, A. & Roumenina, L. T. C3-dependent effector functions of complement. Immunol. Rev. 313, 120–138 (2023).
Google Scholar
Howard, M., Farrar, C. A. & Sacks, S. H. Structural and functional diversity of collectins and ficolins and their relationship to disease. Semin. Immunopathol. 40, 75–85 (2018).
Google Scholar
Fujita, T., Matsushita, M. & Endo, Y. The lectin-complement pathway-its role in innate immunity and evolution. Immunol. Rev. 198, 185–202 (2004).
Google Scholar
Fujita, T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2, 346–353 (2002).
Google Scholar
Weis, W. I., Drickamer, K. & Hendrickson, W. A. Structure of a C-type mannose-binding protein complexed with an oligosaccharide. Nature 360, 127–134 (1992).
Google Scholar
Hansen, S. et al. Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J. Immunol. 185, 6096–6104 (2010).
Google Scholar
Jensen, M. L. et al. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol. Immunol. 44, 856–865 (2007).
Google Scholar
Choteau, L. et al. Role of mannose-binding lectin in intestinal homeostasis and fungal elimination. Mucosal Immunol. 9, 767–776 (2016).
Google Scholar
Medzhitov, R. & Janeway, C. A. Jr Decoding the patterns of self and nonself by the innate immune system. Science 296, 298–300 (2002).
Google Scholar
Turner, M. W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 17, 532–540 (1996).
Google Scholar
Wallis, R. Structural and functional aspects of complement activation by mannose-binding protein. Immunobiology 205, 433–445 (2002).
Google Scholar
Wallis, R. Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway. Immunobiology 212, 289–299 (2007).
Google Scholar
Ambrus, G. et al. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J. Immunol. 170, 1374–1382 (2003).
Google Scholar
Gao, T. et al. Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Signal. Transduct. Target Ther. 7, 318 (2022).
Google Scholar
Hallström, T. & Riesbeck, K. Haemophilus influenzae and the complement system. Trends Microbiol. 18, 258–265 (2010).
Google Scholar
de Boer, E. C. et al. The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation. Clin. Transl. Immunol. 12, e1436 (2023).
Google Scholar
Pangburn, M. K. Spontaneous reformation of the intramolecular thioester in complement protein C3 and low temperature capture of a conformational intermediate capable of reformation. J. Biol. Chem. 267, 8584–8590 (1992).
Google Scholar
Pangburn, M. K., Schreiber, R. D. & Müller-Eberhard, H. J. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J. Exp. Med. 154, 856–867 (1981).
Google Scholar
Michels, M., Volokhina, E. B., van de Kar, N. & van den Heuvel, L. The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy?. Pediatr. Nephrol. 34, 1349–1367 (2019).
Google Scholar
Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785–797 (2010).
Google Scholar
Verdeguer, F. et al. Complement regulation in murine and human hypercholesterolemia and role in the control of macrophage and smooth muscle cell proliferation. Cardiovasc. Res. 76, 340–350 (2007).
Google Scholar
Schepers, A. et al. Inhibition of complement component C3 reduces vein graft atherosclerosis in apolipoprotein E3-Leiden transgenic mice. Circulation 114, 2831–2838 (2006).
Google Scholar
Wang, Y. et al. Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade. Proc. Natl. Acad. Sci. USA 117, 15818–15826 (2020).
Google Scholar
Hill, J. H. & Ward, P. A. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133, 885–900 (1971).
Google Scholar
Nijmeijer, R. et al. C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur. J. Clin. Investig. 34, 803–810 (2004).
Google Scholar
Yasojima, K., Schwab, C., McGeer, E. G. & McGeer, P. L. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ. Res. 83, 860–869 (1998).
Google Scholar
Frey, A., et al. Complement C3c as a biomarker in heart failure. Mediat. Inflamm. 2013, 716902 (2013).
Google Scholar
Nityanand, S. et al. Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease. J. Clin. Immunol. 19, 406–413 (1999).
Google Scholar
Bhatia, V. K. et al. Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice. Am. J. Pathol. 170, 416–426 (2007).
Google Scholar
Jordan, J. E., Montalto, M. C. & Stahl, G. L. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104, 1413–1418 (2001).
Google Scholar
Walsh, M. C. et al. Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J. Immunol. 175, 541–546 (2005).
Google Scholar
Schwaeble, W. J. et al. Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 108, 7523–7528 (2011).
Google Scholar
Markiewski, M. M. & Lambris, J. D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171, 715–727 (2007).
Google Scholar
Ritis, K. et al. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J. Immunol. 177, 4794–4802 (2006).
Google Scholar
Delvaeye, M. & Conway, E. M. Coagulation and innate immune responses: can we view them separately?. Blood 114, 2367–2374 (2009).
Google Scholar
Lam, N., Lee, Y. & Farber, D. L. A guide to adaptive immune memory. Nat. Rev. Immunol. 24, 810–829 (2024).
Google Scholar
Chi, H., Pepper, M. & Thomas, P. G. Principles and therapeutic applications of adaptive immunity. Cell 187, 2052–2078 (2024).
Google Scholar
Eiz-Vesper, B. & Schmetzer, H. M. Antigen-presenting cells: potential of proven and new players in immune therapies. Transfus. Med. Hemother 47, 429–431 (2020).
Google Scholar
Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557–569 (2012).
Google Scholar
Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443–473 (2013).
Google Scholar
Bonilla, F. A. & Oettgen, H. C. Adaptive immunity. J. Allergy Clin. Immunol. 125, S33–S40 (2010).
Google Scholar
Wolf, D. & Ley, K. Immunity and inflammation in atherosclerosis. Circ. Res. 124, 315–327 (2019).
Google Scholar
Akinyemi, D. E., Chevre, R. & Soehnlein, O. Neuro-immune crosstalk in hematopoiesis, inflammation, and repair. Trends Immunol. 45, 597–608 (2024).
Google Scholar
Barry, M. & Bleackley, R. C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2, 401–409 (2002).
Google Scholar
Zhu, J. T Helper Cell Differentiation, Heterogeneity, and Plasticity. Cold Spring Harb. Perspect. Biol. 10, a030338 (2018).
Google Scholar
Wigren, M., Nilsson, J. & Kolbus, D. Lymphocytes in atherosclerosis. Clin. Chim. Acta 413, 1562–1568 (2012).
Google Scholar
Kong, P. et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal. Transduct. Target Ther. 7, 131 (2022).
Google Scholar
Shah, K., Al-Haidari, A., Sun, J. & Kazi, J. U. T cell receptor (TCR) signaling in health and disease. Signal Transduct. Target Ther. 6, 412 (2021).
Google Scholar
Wucherpfennig, K. W. et al. Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling. Cold Spring Harb. Perspect. Biol. 2, a005140 (2010).
Google Scholar
Liew, F. Y. T(H)1 and T(H)2 cells: a historical perspective. Nat. Rev. Immunol. 2, 55–60 (2002).
Google Scholar
Coffman, R. L. Origins of the T(H)1-T(H)2 model: a personal perspective. Nat. Immunol. 7, 539–541 (2006).
Google Scholar
Malissen, B., Grégoire, C., Malissen, M. & Roncagalli, R. Integrative biology of T cell activation. Nat. Immunol. 15, 790–797 (2014).
Google Scholar
Cantor, H. & Boyse, E. A. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J. Exp. Med. 141, 1376–1389 (1975).
Google Scholar
Cerottini, J. C., Nordin, A. A. & Brunner, K. T. Specific in vitro cytotoxicity of thymus-derived lymphocytes sensitized to alloantigens. Nature 228, 1308–1309 (1970).
Google Scholar
Zhang, N. & Bevan, M. J. CD8(+) T cells: foot soldiers of the immune system. Immunity 35, 161–168 (2011).
Google Scholar
Yannelli, J. R., Sullivan, J. A., Mandell, G. L. & Engelhard, V. H. Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinemicrography. J. Immunol. 136, 377–382 (1986).
Google Scholar
Trenn, G., Takayama, H. & Sitkovsky, M. V. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes. Nature 330, 72–74 (1987).
Google Scholar
Boag, S. E. et al. T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. J. Clin. Investig. 125, 3063–3076 (2015).
Google Scholar
Ilatovskaya, D. V. et al. CD8(+) T-cells negatively regulate inflammation post-myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 317, H581–h596 (2019).
Google Scholar
Branchetti, E. et al. Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc. Res. 100, 316–324 (2013).
Google Scholar
Curato, C. et al. Identification of noncytotoxic and IL-10-producing CD8+AT2R+ T cell population in response to ischemic heart injury. J. Immunol. 185, 6286–6293 (2010).
Google Scholar
Elhage, R. et al. Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. Am. J. Pathol. 165, 2013–2018 (2004).
Google Scholar
Sage, A. P. et al. X-box binding protein-1 dependent plasma cell responses limit the development of atherosclerosis. Circ. Res. 121, 270–281 (2017).
Google Scholar
Taleb, S., Tedgui, A. & Mallat, Z. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Arterioscler Thromb. Vasc. Biol. 35, 258–264 (2015).
Google Scholar
Weirather, J. et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ. Res. 115, 55–67 (2014).
Google Scholar
Hofmann, U. et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 125, 1652–1663 (2012).
Google Scholar
Murphy, T. J. et al. CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J. Immunol. 174, 2957–2963 (2005).
Google Scholar
Jung, M. et al. IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation. Basic Res. Cardiol. 112, 33 (2017).
Google Scholar
Ikeuchi, M. et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc. Res. 64, 526–535 (2004).
Google Scholar
Akkaya, M., Kwak, K. & Pierce, S. K. B cell memory: building two walls of protection against pathogens. Nat. Rev. Immunol. 20, 229–238 (2020).
Google Scholar
Kwak, K., Akkaya, M. & Pierce, S. K. B cell signaling in context. Nat. Immunol. 20, 963–969 (2019).
Google Scholar
Labeur-Iurman, L. & Harker, J. A. Mechanisms of antibody mediated immunity – Distinct in early life. Int. J. Biochem. Cell Biol. 172, 106588 (2024).
Google Scholar
Casadevall, A. & Pirofski, L. A. A new synthesis for antibody-mediated immunity. Nat. Immunol. 13, 21–28 (2011).
Google Scholar
Hoehn, K. B., Fowler, A., Lunter, G. & Pybus, O. G. The diversity and molecular evolution of B-cell receptors during infection. Mol. Biol. Evol. 33, 1147–1157 (2016).
Google Scholar
Sharma, R. et al. Distinct metabolic requirements regulate B cell activation and germinal center responses. Nat. Immunol. 24, 1358–1369 (2023).
Google Scholar
Hägglöf, T. et al. Continuous germinal center invasion contributes to the diversity of the immune response. Cell 186, 147–161.e115 (2023).
Google Scholar
Horckmans, M. et al. Pericardial adipose tissue regulates granulopoiesis, fibrosis, and cardiac function after myocardial infarction. Circulation 137, 948–960 (2018).
Google Scholar
Wu, L. et al. IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction. Proc. Natl. Acad. Sci. USA 116, 21673–21684 (2019).
Google Scholar
Ma, S., Meng, Z., Chen, R. & Guan, K. L. The hippo pathway: biology and pathophysiology. Annu. Rev. Biochem. 88, 577–604 (2019).
Google Scholar
Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811–828 (2015).
Google Scholar
Zhang, Q. et al. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade. Nat. Cell Biol. 19, 362–374 (2017).
Google Scholar
Wang, S. et al. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKvarepsilon-mediated phosphorylation. Nat. Immunol. 18, 733–743 (2017).
Google Scholar
Liu, B. et al. Toll receptor-mediated hippo signaling controls innate immunity in drosophila. Cell 164, 406–419 (2016).
Google Scholar
Du, X. et al. Hippo/Mst signalling couples metabolic state and immune function of CD8alpha(+) dendritic cells. Nature 558, 141–145 (2018).
Google Scholar
Shi, H. et al. Hippo kinases Mst1 and Mst2 sense and amplify IL-2R-STAT5 signaling in regulatory T cells to establish stable regulatory activity. Immunity 49, 899–914.e6 (2018).
Google Scholar
Odashima, M. et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction. Circ. Res. 100, 1344–1352 (2007).
Google Scholar
Del Re, D. P. et al. Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL. Mol. Cell 54, 639–650 (2014).
Google Scholar
Gao, Y. et al. YAP/TEAD1 complex is a default repressor of cardiac toll-like receptor genes. Int. J. Mol. Sci. 22, 6649 (2021).
Google Scholar
Wang, X. et al. TLR3 mediates repair and regeneration of damaged neonatal heart through glycolysis dependent YAP1 regulated miR-152 expression. Cell Death Differ. 25, 966–982 (2018).
Google Scholar
Lin, Z. et al. Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model. Circ. Res. 115, 354–363 (2014).
Google Scholar
Chen, J. et al. aYAP modRNA reduces cardiac inflammation and hypertrophy in a murine ischemia-reperfusion model. Life Sci. Alliance 3, e201900424 (2020).
Google Scholar
Wang, P. et al. The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy. Basic Res. Cardiol. 109, 435 (2014).
Google Scholar
Xiong, Z. et al. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165806 (2020).
Google Scholar
Wang, K. C. et al. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis. Proc. Natl. Acad. Sci. USA 113, 11525–11530 (2016).
Google Scholar
Wang, L. et al. Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow. Nature 540, 579–582 (2016).
Google Scholar
Xu, Q. et al. Activation of yes-associated protein/PDZ-binding motif pathway contributes to endothelial dysfunction and vascular inflammation in angiotensinII hypertension. Front. Physiol. 12, 732084 (2021).
Google Scholar
Niehrs, C. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13, 767–779 (2012).
Google Scholar
Liu, J. et al. Wnt/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal. Transduct. Target Ther. 7, 3 (2022).
Google Scholar
Nusse, R. & Clevers, H. Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985–999 (2017).
Google Scholar
Ma, B. & Hottiger, M. O. Crosstalk between Wnt/beta-catenin and NF-kappaB signaling pathway during inflammation. Front. Immunol. 7, 378 (2016).
Google Scholar
Trinath, J. et al. The WNT signaling pathway contributes to dectin-1-dependent inhibition of Toll-like receptor-induced inflammatory signature. Mol. Cell Biol. 34, 4301–4314 (2014).
Google Scholar
Aisagbonhi, O. et al. Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition. Dis. Model Mech. 4, 469–483 (2011).
Google Scholar
Moon, J. et al. Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist. Proc. Natl. Acad. Sci. USA 114, 1649–1654 (2017).
Google Scholar
Blumenthal, A. et al. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108, 965–973 (2006).
Google Scholar
Barandon, L. et al. Secreted frizzled-related protein-1 improves postinfarction scar formation through a modulation of inflammatory response. Arterioscler Thromb. Vasc. Biol. 31, e80–e87 (2011).
Google Scholar
Lin, J. C. et al. beta-Catenin overexpression causes an increase in inflammatory cytokines and NF-kappaB activation in cardiomyocytes. Cell Mol. Biol. 63, 17–22 (2016).
Google Scholar
van de Schans, V. A. et al. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy. Hypertension 49, 473–480 (2007).
Google Scholar
Awan, S. et al. Wnt5a promotes lysosomal cholesterol egress and protects against atherosclerosis. Circ. Res. 130, 184–199 (2022).
Google Scholar
Bhatt, P. M. & Malgor, R. Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders. Atherosclerosis 237, 155–162 (2014).
Google Scholar
Schaale, K. et al. Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur. J. Cell Biol. 90, 553–559 (2011).
Google Scholar
Borrell-Pages, M., Romero, J. C., Juan-Babot, O. & Badimon, L. Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages. Eur. Heart J. 32, 2841–2850 (2011).
Google Scholar
Wang, F. et al. Myeloid beta-catenin deficiency exacerbates atherosclerosis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb. Vasc. Biol. 38, 1468–1478 (2018).
Google Scholar
Schwartz, D. M. et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat. Rev. Drug Discov. 16, 843–862 (2017).
Google Scholar
O’Shea, J. J. et al. Janus kinase inhibitors in autoimmune diseases. Ann. Rheum. Dis. 72, ii111–ii115 (2013).
Google Scholar
Brooks, A. J. et al. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science 344, 1249783 (2014).
Google Scholar
Schwartz, D. M., Bonelli, M., Gadina, M. & O’Shea, J. J. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nat. Rev. Rheumatol. 12, 25–36 (2016).
Google Scholar
O’Shea, J. J., Holland, S. M. & Staudt, L. M. JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 368, 161–170 (2013).
Google Scholar
Banerjee, S. et al. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 77, 521–546 (2017).
Google Scholar
McCormick, J. et al. Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injury. FASEB J. 20, 2115–2117 (2006).
Google Scholar
Negoro, S. et al. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc. Res. 47, 797–805 (2000).
Google Scholar
Kunisada, K. et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc. Natl. Acad. Sci. USA 97, 315–319 (2000).
Google Scholar
Hilfiker-Kleiner, D. et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ. Res. 95, 187–195 (2004).
Google Scholar
Dawn, B. et al. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc. Res. 64, 61–71 (2004).
Google Scholar
Xuan, Y. T. et al. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ. Res. 84, 1095–1109 (1999).
Google Scholar
Dotan, I. et al. Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux. Commun. Biol. 5, 132 (2022).
Google Scholar
An, H. J. et al. STAT3/NF‑kappaB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF‑kappaB signaling pathway in a mouse model of atherosclerosis. Int. J. Mol. Med. 51, 37 (2023).
Google Scholar
Dor, Y. & Cedar, H. Principles of DNA methylation and their implications for biology and medicine. Lancet 392, 777–786 (2018).
Google Scholar
Moore, L. D., Le, T. & Fan, G. DNA methylation and its basic function. Neuropsychopharmacology 38, 23–38 (2013).
Google Scholar
Ying, Z. et al. Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24. Cell Mol. Immunol. 20, 1487–1498 (2023).
Google Scholar
Cardenas, A., Fadadu, R. & Bunyavanich, S. Climate change and epigenetic biomarkers in allergic and airway diseases. J. Allergy Clin. Immunol. 152, 1060–1072 (2023).
Google Scholar
Perez-Garcia, J., Cardenas, A., Lorenzo-Diaz, F. & Pino-Yanes, M. Precision medicine for asthma treatment: Unlocking the potential of the epigenome and microbiome. J. Allergy Clin. Immunol. S0091-6749, 00634–1 (2024).
Zheng, Y. et al. Association of cardiovascular health through young adulthood with genome-wide DNA methylation patterns in midlife: the CARDIA study. Circulation 146, 94–109 (2022).
Google Scholar
Kuznetsova, T., Prange, K. H. M., Glass, C. K. & de Winther, M. P. J. Transcriptional and epigenetic regulation of macrophages in atherosclerosis. Nat. Rev. Cardiol. 17, 216–228 (2020).
Google Scholar
Chang, C. P., Su, Y. C., Hu, C. W. & Lei, H. Y. TLR2-dependent selective autophagy regulates NF-κB lysosomal degradation in hepatoma-derived M2 macrophage differentiation. Cell Death Differ. 20, 515–523 (2013).
Google Scholar
Zhao, C. et al. DNA methyltransferase 1 deficiency improves macrophage motility and wound healing by ameliorating cholesterol accumulation. NPJ Regen. Med. 8, 29 (2023).
Google Scholar
Millán-Zambrano, G., Burton, A., Bannister, A. J. & Schneider, R. Histone post-translational modifications – cause and consequence of genome function. Nat. Rev. Genet. 23, 563–580 (2022).
Google Scholar
Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381–395 (2011).
Google Scholar
Li, Y. et al. Id2 epigenetically controls CD8(+) T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex. Cell Mol. Immunol. 21, 292–308 (2024).
Google Scholar
Jacobs, M. M. E. et al. Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling. Cell Rep. 43, 114664 (2024).
Google Scholar
Wang, N. et al. Histone lactylation boosts reparative gene activation post-myocardial infarction. Circ. Res. 131, 893–908 (2022).
Google Scholar
Lan, C. et al. Inhibition of DYRK1A, via histone modification, promotes cardiomyocyte cell cycle activation and cardiac repair after myocardial infarction. EBioMedicine 82, 104139 (2022).
Google Scholar
Zhang, S. et al. Targeting NPM1 epigenetically promotes postinfarction cardiac repair by reprogramming reparative macrophage metabolism. Circulation 149, 1982–2001 (2024).
Google Scholar
Hoeksema, M. A. et al. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol. Med. 6, 1124–1132 (2014).
Google Scholar
Vlad, M. L. et al. Histone acetyltransferase-dependent pathways mediate upregulation of NADPH oxidase 5 in human macrophages under inflammatory conditions: a potential mechanism of reactive oxygen species overproduction in atherosclerosis. Oxid. Med. Cell Longev. 2019, 3201062 (2019).
Gao, Y. et al. LNCGM1082-mediated NLRC4 activation drives resistance to bacterial infection. Cell Mol. Immunol. 20, 475–488 (2023).
Google Scholar
Kim, J., et al. An enhancer RNA recruits KMT2A to regulate transcription of Myb. Cell Rep. 43, 114378 (2024).
Google Scholar
Lu, Y. et al. The NF-κB-responsive long noncoding RNA FIRRE regulates posttranscriptional regulation of inflammatory gene expression through interacting with hnRNPU. J. Immunol. 199, 3571–3582 (2017).
Google Scholar
Li, J. et al. A novel piwi-interacting RNA associates with type 2-high asthma phenotypes. J. Allergy Clin. Immunol. 153, 695–704 (2024).
Google Scholar
Nemeth, K., Bayraktar, R., Ferracin, M. & Calin, G. A. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat. Rev. Genet. 25, 211–232 (2024).
Google Scholar
Gomes, C. P. C. et al. Regulatory RNAs in heart failure. Circulation 141, 313–328 (2020).
Google Scholar
Han, Y., Ma, J., Wang, J. & Wang, L. Silencing of H19 inhibits the adipogenesis and inflammation response in ox-LDL-treated Raw264.7 cells by up-regulating miR-130b. Mol. Immunol. 93, 107–114 (2018).
Google Scholar
Fasolo, F. et al. Long noncoding RNA MIAT controls advanced atherosclerotic lesion formation and plaque destabilization. Circulation 144, 1567–1583 (2021).
Google Scholar
Shin, J. J. et al. Roles of lncRNAs in NF-κB-mediated macrophage inflammation and their implications in the pathogenesis of human diseases. Int. J. Mol. Sci. 25, 2670 (2024).
Cynn, E. et al. Human macrophage long intergenic noncoding RNA, SIMALR, suppresses inflammatory macrophage apoptosis via NTN1 (Netrin-1). Arterioscler Thromb. Vasc. Biol. 43, 286–299 (2023).
Google Scholar
Wang, S. et al. LncRNA CCRR attenuates postmyocardial infarction inflammatory response by inhibiting the TLR signalling pathway. Can. J. Cardiol. 40, 710–725 (2024).
Google Scholar
Ramanujam, D. et al. MicroRNA-21-dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload. Circulation 143, 1513–1525 (2021).
Google Scholar
Nosalski, R. et al. T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension. Circ. Res. 126, 988–1003 (2020).
Google Scholar
Li, H. et al. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4. Cardiovasc. Res. 116, 1323–1334 (2020).
Google Scholar
Wang, Y. et al. CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction. Theranostics 11, 6315–6333 (2021).
Google Scholar
Liu, Y. et al. The RNA m(6)A demethylase ALKBH5 drives emergency granulopoiesis and neutrophil mobilization by upregulating G-CSFR expression. Cell Mol. Immunol. 21, 6–18 (2024).
Google Scholar
Li, B. et al. TMK4-mediated FIP37 phosphorylation regulates auxin-triggered N(6)-methyladenosine modification of auxin biosynthetic genes in Arabidopsis. Cell Rep. 43, 114597 (2024).
Google Scholar
Wang, C. et al. RNA modification in cardiovascular disease: implications for therapeutic interventions. Signal Transduct. Target Ther. 8, 412 (2023).
Google Scholar
Cui, L. et al. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct. Target Ther. 7, 334 (2022).
Google Scholar
Han, D. & Xu, M. M. RNA modification in the immune system. Annu. Rev. Immunol. 41, 73–98 (2023).
Google Scholar
Wu, H. et al. Dendritic cells with METTL3 gene knockdown exhibit immature properties and prolong allograft survival. Genes Immun. 21, 193–202 (2020).
Google Scholar
Li, Y. et al. Low RNA stability signifies increased post-transcriptional regulation of cell identity genes. Nucleic Acids Res. 51, 6020–6038 (2023).
Google Scholar
Li, Q. et al. METTL3 (Methyltransferase Like 3)-dependent N6-methyladenosine modification on braf mRNA promotes macrophage inflammatory response and atherosclerosis in mice. Arterioscler Thromb. Vasc. Biol. 43, 755–773 (2023).
Google Scholar
Jian, D. et al. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics 10, 8939–8956 (2020).
Google Scholar
Zheng, Y. et al. Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-κB/IL-6 signaling pathway. Cell Mol. Life Sci. 79, 311 (2022).
Google Scholar
Zheng, P. F., et al. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy. Sci. Rep. 13, 5904 (2023).
Google Scholar
Wang, K. et al. HNEAP regulates necroptosis of cardiomyocytes by suppressing the m(5) C methylation of Atf7 mRNA. Adv. Sci.10, e2304329 (2023).
Google Scholar
Hou, J., et al. TGM1/3-mediated transamidation of Exo70 promotes tumor metastasis upon LKB1 inactivation. Cell Rep. 43, 114604 (2024).
Google Scholar
Guo, J., Zheng, H. & Xiong, S. SENP6 restricts the IFN-I-induced signaling pathway and antiviral activity by deSUMOylating USP8. Cell Mol. Immunol. 21, 892–904 (2024).
Google Scholar
Liu, J., Qian, C. & Cao, X. Post-translational modification control of innate immunity. Immunity 45, 15–30 (2016).
Google Scholar
Xia, B. & Zhao, J. Unraveling novel strategies: targeting Miz1 for degradation to enhance antiviral defense against influenza A virus. J. Respir. Biol. Transl. Med. 1, 10009 (2024).
Google Scholar
Taleb, S. J. et al. Molecular regulation of transforming growth factor-β1-induced thioredoxin-interacting protein ubiquitination and proteasomal degradation in lung fibroblasts: implication in pulmonary fibrosis. J. Respir. Biol. Transl. Med. 1, 10002 (2024).
Google Scholar
An, Z. et al. Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-κB signaling in macrophages. Cell Cycle 18, 2928–2938 (2019).
Google Scholar
Yang, B., et al. Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway. Cell Death Dis. 14, 419 (2023).
Google Scholar
Liu, M., et al. Macrophage K63-linked ubiquitination of YAP promotes its nuclear localization and exacerbates atherosclerosis. Cell Rep. 32, 107990 (2020).
Google Scholar
Chen, H., et al. The E3 ubiquitin ligase WWP2 regulates pro-fibrogenic monocyte infiltration and activity in heart fibrosis. Nat. Commun. 13, 7375 (2022).
Google Scholar
Yang, L. L., et al. E3 ubiquitin ligase RNF5 attenuates pathological cardiac hypertrophy through STING. Cell Death Dis. 13, 889 (2022).
Google Scholar
González-Amor, M. et al. Interferon-stimulated gene 15 pathway is a novel mediator of endothelial dysfunction and aneurysms development in angiotensin II infused mice through increased oxidative stress. Cardiovasc. Res. 118, 3250–3268 (2022).
Google Scholar
Zhou, W., et al. Local thiamet-G delivery by a thermosensitive hydrogel confers ischemic cardiac repair via myeloid M2-like activation in a STAT6 O-GlcNAcylation-dependent manner. Int. Immunopharmacol. 131, 111883 (2024).
Google Scholar
Venkatakrishnan, A. J. et al. Molecular signatures of G-protein-coupled receptors. Nature 494, 185–194 (2013).
Google Scholar
Park, J. C. et al. Fine-tuning GPCR-mediated neuromodulation by biasing signaling through different G protein subunits. Mol. Cell 83, 2540–2558.e2512 (2023).
Google Scholar
Liu, K. et al. Structural basis of CXC chemokine receptor 2 activation and signalling. Nature 585, 135–140 (2020).
Google Scholar
Bajpai, G. et al. Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circ. Res. 124, 263–278 (2019).
Google Scholar
Wong, N. R. et al. Resident cardiac macrophages mediate adaptive myocardial remodeling. Immunity 54, 2072–2088.e2077 (2021).
Google Scholar
Klein, K. R. et al. Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development. Dev. cell 30, 528–540 (2014).
Google Scholar
Lill, N. L. & Sever, N. I. Where EGF receptors transmit their signals. Sci. Signal. 5, pe41 (2012).
Google Scholar
Okyere, A. D. et al. Myeloid cell-specific deletion of epidermal growth factor receptor aggravates acute cardiac injury. Clin. Sci. 137, 1513–1531 (2023).
Google Scholar
Korf-Klingebiel, M. et al. Myeloid-derived growth factor protects against pressure overload-induced heart failure by preserving sarco/endoplasmic reticulum Ca(2+)-ATPase expression in cardiomyocytes. Circulation 144, 1227–1240 (2021).
Google Scholar
Zeboudj, L. et al. Selective EGF-receptor inhibition in CD4(+) T Cells Induces anergy and limits atherosclerosis. J. Am. Coll. Cardiol. 71, 160–172 (2018).
Google Scholar
Jia, D. et al. Interleukin-35 promotes macrophage survival and improves wound healing after myocardial infarction in mice. Circ. Res. 124, 1323–1336 (2019).
Google Scholar
Singla, B. et al. CD47 activation by thrombospondin-1 in lymphatic endothelial cells suppresses lymphangiogenesis and promotes atherosclerosis. Arterioscler Thromb. Vasc. Biol. 43, 1234–1250 (2023).
Google Scholar
Higashi, Y. et al. Insulin-like growth factor-1 receptor deficiency in macrophages accelerates atherosclerosis and induces an unstable plaque phenotype in apolipoprotein E-deficient mice. Circulation 133, 2263–2278 (2016).
Google Scholar
Meng, Z. et al. Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis. Eur. Heart J. 44, 2763–2783 (2023).
Google Scholar
Chen, B. et al. Macrophage Smad3 protects the infarcted heart, stimulating phagocytosis and regulating inflammation. Circ. Res. 125, 55–70 (2019).
Google Scholar
Wang, Z. et al. Myocardial protection by heparin-based coacervate of FGF10. Bioact. Mater. 6, 1867–1877 (2021).
Google Scholar
Shi, S., et al. Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy. Cell Commun. Signal. 21, 61 (2023).
Google Scholar
Cai, S. et al. Mitochondrial dysfunction in macrophages promotes inflammation and suppresses repair after myocardial infarction. J. Clin. Invest. 133, e159498 (2023).
Dikalova, A. E. et al. Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ. Res. 126, 439–452 (2020).
Google Scholar
Wang, Y. P. & Lei, Q. Y. Metabolite sensing and signaling in cell metabolism. Signal. Transduct. Target Ther. 3, 30 (2018).
Google Scholar
Bekkering, S. et al. Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Atherosclerosis 254, 228–236 (2016).
Google Scholar
Mouton, A. J., Li, X., Hall, M. E. & Hall, J. E. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ. Res. 126, 789–806 (2020).
Google Scholar
Shirai, T. et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J. Exp. Med. 213, 337–354 (2016).
Google Scholar
Watanabe, R. et al. Glucose metabolism controls disease-specific signatures of macrophage effector functions. JCI Insight 3, e123047 (2018).
Google Scholar
Liu, T. Regulation of inflammasome by autophagy. Adv. Exp. Med. Biol. 1209, 109–123 (2019).
Google Scholar
Del Re, D. P. et al. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol. Rev. 99, 1765–1817 (2019).
Google Scholar
Linton, M. F. et al. Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ. J. 80, 2259–2268 (2016).
Google Scholar
Kojima, Y. et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536, 86–90 (2016).
Google Scholar
Gerlach, B. D. et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 33, 2445–2463.e2448 (2021).
Google Scholar
Lv, J. J. et al. CD147 sparks atherosclerosis by driving M1 phenotype and impairing efferocytosis. Circ. Res. 134, 165–185 (2024).
Google Scholar
Fang, S. et al. IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: Irgm1(+/-) mice display increases atherosclerotic plaque stability. Theranostics 11, 9358–9375 (2021).
Google Scholar
Guntupalli, V. et al. Solute carrier family 26 member 4 (SLC26A4), a potential therapeutic target for asthma. J. Respir. Biol. Transl. Med. 1, (2024).
Tang, L., Yu, X., Zheng, Y. & Zhou, N. Inhibiting SLC26A4 reverses cardiac hypertrophy in H9C2 cells and in rats. PeerJ 8, e8253 (2020).
Google Scholar
Xu, X. et al. Macrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy. Cardiovasc. Res. 99, 412–421 (2013).
Google Scholar
Tang, Y. et al. Autophagy protects mitochondrial health in heart failure. Heart Fail Rev. 29, 113–123 (2024).
Google Scholar
Chan, S. H. et al. SIRT1 inhibition causes oxidative stress and inflammation in patients with coronary artery disease. Redox Biol. 13, 301–309 (2017).
Google Scholar
Administration., U. S. F. A. D. What are biologics? Questions and answers., (2018).
Zhu, X. et al. A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice. Front. Immunol. 14, e159498 (2023).
De Maio, A. Extracellular heat shock proteins, cellular export vesicles, and the stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell Stress Chaperones 16, 235–249 (2011).
Google Scholar
Bochaton, T. et al. Heat shock protein 70 as a biomarker of clinical outcomes after STEMI. J. Am. Coll. Cardiol. 75, 122–124 (2020).
Google Scholar
Chang, T. T., Yang, H. Y., Chen, C. & Chen, J. W. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation. Int. J. Mol. Sci. 21, 6567 (2020).
Google Scholar
Nakahashi-Oda, C. et al. CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke. Sci. Immunol. 6, eabe7915 (2021).
Google Scholar
Wolf, D. et al. A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nat. Commun. 9, 525 (2018).
Google Scholar
Gustafsson, K. et al. Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody-drug conjugate. Blood Adv. 7, 6964–6973 (2023).
Google Scholar
Shvedova, M. et al. c-Jun N-terminal kinases (JNKs) in myocardial and cerebral ischemia/reperfusion injury. Front. Pharmacol. 9, 715 (2018).
Google Scholar
Zidar, N., Dolenc-Strazar, Z., Jeruc, J. & Stajer, D. Immunohistochemical expression of activated caspase-3 in human myocardial infarction. Virchows Arch. 448, 75–79 (2006).
Google Scholar
Balsam, L. B., Kofidis, T. & Robbins, R. C. Caspase-3 inhibition preserves myocardial geometry and long-term function after infarction. J. Surg. Res. 124, 194–200 (2005).
Google Scholar
Seropian, I. M., Cassaglia, P., Miksztowicz, V. & González, G. E. Unraveling the role of galectin-3 in cardiac pathology and physiology. Front. Physiol. 14, 1304735 (2023).
Google Scholar
Li, M. et al. Value of galectin-3 in acute myocardial infarction. Am. J. Cardiovasc. Drugs 20, 333–342 (2020).
Google Scholar
Frangogiannis, N. G. Targeting galectin-3 in myocardial infarction: a unique opportunity for biomarker-guided therapy. Cardiovasc. Res. 119, 2495–2496 (2023).
Google Scholar
Poznyak, A. V. et al. NADPH oxidases and their role in atherosclerosis. Biomedicines 8, 206 (2020).
Google Scholar
Zhang, Y., Murugesan, P., Huang, K. & Cai, H. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat. Rev. Cardiol. 17, 170–194 (2020).
Google Scholar
Ulleryd, M. A. et al. Stimulation of alpha 7 nicotinic acetylcholine receptor (α7nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells. Atherosclerosis 287, 122–133 (2019).
Google Scholar
Garscha, U. et al. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly. Biochem. Pharmacol. 119, 17–26 (2016).
Google Scholar
Abdel-Magid, A. F. Endothelial lipase inhibitors for the treatment of atherosclerosis and cardiovascular disorders. ACS Med. Chem. Lett. 4, 1016–1017 (2013).
Google Scholar
Yasuda, T. et al. Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. J. Atheroscler. Thromb. 14, 192–201 (2007).
Google Scholar
Wald, D., Gupta, K., Lu, Y. & Moreton, S. Targeting leukocyte derived MPO in heart failure. Blood 130, 3570 (2017).
Nguyen, N. et al. Abstract 14871: APD588, a novel, selective S1P receptor modulator, regulates inflammatory responses and attenuates cardiac dysfunction following experimental myocardial infarction in mice. Circulation 142, A14871–A14871 (2020).
Google Scholar
Phan, F. et al. Sphingosine-1-phosphate signalling in the heart: exploring emerging perspectives in cardiopathology. FEBS Lett. 598, 2641–2655 (2024).
Google Scholar
Zhang, F. et al. Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 310, H250–H261 (2016).
Google Scholar
Reitz, C. J. et al. SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome. Commun. Biol. 2, 353 (2019).
Google Scholar
Wang, D. et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat. Rev. Endocrinol. 17, 592–607 (2021).
Google Scholar
Toldo, S. & Abbate, A. The NLRP3 inflammasome in acute myocardial infarction. Nat. Rev. Cardiol. 15, 203–214 (2018).
Google Scholar
Jia, L. et al. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease. Atherosclerosis 228, 346–352 (2013).
Google Scholar
Komal, S. et al. Epigenetic regulation of macrophage polarization in cardiovascular diseases. Pharmacuticals 16, 141 (2023).
Google Scholar
Bansal, S. S. et al. Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy. Circulation 139, 206–221 (2019).
Google Scholar
Lu, X. et al. Reactive oxygen species responsive multifunctional fusion extracellular nanovesicles: prospective treatments for acute heart transplant rejection. Adv. Mater. 36, e2406758 (2024).
Zhou, J., et al. Natural melanin/alginate hydrogels achieve cardiac repair through ROS scavenging and macrophage polarization. Adv. Sci. 8, e2100505 (2021).
Google Scholar
Ridker, P. M. et al. Low-dose methotrexate for the prevention of atherosclerotic events. N. Engl. J. Med. 380, 752–762 (2019).
Google Scholar
Cormack, S. et al. Effect of ciclosporin on safety, lymphocyte kinetics and left ventricular remodelling in acute myocardial infarction. Br. J. Clin. Pharmacol. 86, 1387–1397 (2020).
Google Scholar
Ali, R. M. et al. Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon. JACC Cardiovasc. Inter. 12, 558–566 (2019).
Google Scholar
Rodriguez, A. E. et al. Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial. Catheter Cardiovasc. Inter. 80, 385–394 (2012).
Google Scholar
Stähli, B. E. et al. Mammalian target of rapamycin inhibition in patients with ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 80, 1802–1814 (2022).
Google Scholar
El Sayed, H. et al. A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous revascularization. J. Vasc. Surg. 63, 133–141.e131 (2016).
Google Scholar
Abbate, A. et al. Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction. J. Am. Heart Assoc. 9, e014941 (2020).
Google Scholar
Myachikova, V. Y. et al. Treatment of idiopathic recurrent pericarditis with goflikicept: phase II/III study results. J. Am. Coll. Cardiol. 82, 30–40 (2023).
Google Scholar
Ridker, P. M. et al. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 397, 2060–2069 (2021).
Google Scholar
Kleveland, O. et al. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur. Heart J. 37, 2406–2413 (2016).
Google Scholar
Broch, K. et al. Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol. 77, 1845–1855 (2021).
Google Scholar
Meyer, M. A. S. et al. Treatment effects of interleukin-6 receptor antibodies for modulating the systemic inflammatory response after out-of-hospital cardiac arrest (The IMICA Trial): a double-blinded, placebo-controlled, single-center, randomized, clinical trial. Circulation 143, 1841–1851 (2021).
Google Scholar
Zhang, F. S. et al. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review. Acta Pharmacol. Sin. 43, 2173–2190 (2022).
Google Scholar
Klück, V. et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2, e270–e280 (2020).
Google Scholar
Wohlford, G. F. et al. Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure. J. Cardiovasc. Pharmacol. 77, 49–60 (2020).
Google Scholar
Lin, S. H. et al. Treatment with TNF-α inhibitor rectifies M1 macrophage polarization from blood CD14+ monocytes in patients with psoriasis independent of STAT1 and IRF-1 activation. J. Dermatol. Sci. 91, 276–284 (2018).
Google Scholar
Colombo, A. et al. A double-blind randomised study to evaluate the efficacy and safety of bindarit in preventing coronary stent restenosis. EuroIntervention 12, e1385–e1394 (2016).
Google Scholar
Lam, C. S. P. et al. Myeloperoxidase inhibition in heart failure with preserved or mildly reduced ejection fraction: SATELLITE trial results. J. Card. Fail 30, 104–110 (2024).
Google Scholar
Hernández-Jiménez, M. et al. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers. Mol. Ther. Nucleic Acids 28, 124–135 (2022).
Google Scholar
Willingham, S. B. et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc. Natl. Acad. Sci. USA 109, 6662–6667 (2012).
Google Scholar
D’Amico, M. et al. Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment. Faseb J. 14, 1867–1869 (2000).
Google Scholar
Ferraro, B. et al. Pro-angiogenic macrophage phenotype to promote myocardial repair. J. Am. Coll. Cardiol. 73, 2990–3002 (2019).
Google Scholar
Chen, J. et al. The annexin-A1 mimetic RTP-026 promotes acute cardioprotection through modulation of immune cell activation. Pharmacol. Res. 198, 107005 (2023).
Google Scholar
Gelevski, D. et al. Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: experience with expanded access protocol. Muscle Nerve 67, 354–362 (2023).
Google Scholar
Zhao, R. et al. Recent advances in CXCL12/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy. Pharmaceutics 14, 1541 (2022).
Google Scholar
Means, C. K. & Brown, J. H. Sphingosine-1-phosphate receptor signalling in the heart. Cardiovasc. Res. 82, 193–200 (2009).
Google Scholar
Guo, Y., et al. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 11, 349 (2020).
Google Scholar
Hare, J. M. et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277–2286 (2009).
Google Scholar
Lee, J. W. et al. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J. Korean Med. Sci. 29, 23–31 (2014).
Google Scholar
Gao, L. R., et al. Intracoronary infusion of Wharton’s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 13, 162 (2015).
Google Scholar
Qayyum, A. A. et al. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure. ESC Heart Fail 10, 1170–1183 (2023).
Google Scholar
Ikeda, M. et al. Immunomodulatory cell therapy using αGalCer-pulsed dendritic cells ameliorates heart failure in a murine dilated cardiomyopathy model. Circ. Heart Fail 15, e009366 (2022).
Google Scholar
Chullikana, A. et al. Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction. Cytotherapy 17, 250–261 (2015).
Google Scholar
Butler, J. et al. Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II-A randomized trial. Circ. Res. 120, 332–340 (2017).
Google Scholar
Florea, V. et al. Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (The TRIDENT Study). Circ. Res. 121, 1279–1290 (2017).
Google Scholar
Bartolucci, J. et al. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ. Res. 121, 1192–1204 (2017).
Google Scholar
Ulus, A. T. et al. Intramyocardial transplantation of umbilical cord mesenchymal stromal cells in chronic ischemic cardiomyopathy: a controlled, randomized clinical trial (HUC-HEART Trial). Int. J. Stem Cells 13, 364–376 (2020).
Google Scholar
Nidorf, S. M. et al. Colchicine in patients with chronic coronary disease. N. Engl. J. Med. 383, 1838–1847 (2020).
Google Scholar
link
